EPS: US$3.07 (up from US$2.49 in 1Q 2024). We've discovered 2 warning signs about Eli Lilly. View them for free. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst ...

Ranking all 'Cobra Kai' seasons from worst to best—breaking down the action, drama, and nostalgia that made the series ...

David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky ...

Eli Lilly LLY-5.46%decrease; red down pointing triangle revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged ...

The new threat has Eli Lilly investors running scared, but Wall Street analysts insist Eli Lilly stock is still a buy. GLP-1 drug prices are falling. That's good news for patients, but perhaps not ...

Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. Stream NBC 5 ...

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to ...

Eli Lilly said the revision reflects a $1.57 billion deal charge recorded in the first quarter, which is primarily related to its acquisition of a certain oral cancer drug from Scorpion Therapeutics.

This article contains spoilers for the Cobra Kai series finale. After six seasons, two different streaming services, and 65 episodes, Cobra Kai has swept the leg one last time on Netflix ...

President Trump recently warned big drugmakers that a pharmaceutical "tariff wall" is coming. His administration is reportedly considering implementing an even bigger threat to the U.S ...